Skinvisible, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
December 03, 2019 at 06:05 am EST
Share
Skinvisible, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 11,295 compared to USD 18,675 a year ago. Operating loss was USD 136,925 compared to USD 138,636 a year ago. Net loss was USD 348,742 compared to net income of USD 636,103 a year ago. Basic loss per share from continuing operations was USD 0.12 compared to basic earnings per share from continuing operations of USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to diluted earnings per share from continuing operations of USD 0.02 a year ago. For the nine months, sales was USD 32,379 compared to USD 56,591 a year ago. Operating loss was USD 422,313 compared to USD 444,511 a year ago. Net loss was USD 1.274 million compared to net income of USD 335,969 a year ago. Basic loss per share from continuing operations was USD 0.44 compared to basic earnings per share from continuing operations of USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.44 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company is engaged in developing and patenting a polymer delivery system, Invisicare and formulated over forty topical skin products. The Company's product, Pivotal, is a patented polymer delivery system technology Invisicare. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents.